EMAMILTD - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.8
| Stock Code | EMAMILTD | Market Cap | 17,702 Cr. | Current Price | 406 ₹ | High / Low | 655 ₹ |
| Stock P/E | 20.2 | Book Value | 71.8 ₹ | Dividend Yield | 2.46 % | ROCE | 34.0 % |
| ROE | 31.5 % | Face Value | 1.00 ₹ | DMA 50 | 473 ₹ | DMA 200 | 529 ₹ |
| Chg in FII Hold | -1.90 % | Chg in DII Hold | 1.72 % | PAT Qtr | 339 Cr. | PAT Prev Qtr | 182 Cr. |
| RSI | 23.0 | MACD | -20.2 | Volume | 2,68,390 | Avg Vol 1Wk | 7,83,266 |
| Low price | 404 ₹ | High price | 655 ₹ | PEG Ratio | 25.6 | Debt to equity | 0.01 |
| 52w Index | 0.72 % | Qtr Profit Var | 21.3 % | EPS | 19.8 ₹ | Industry PE | 41.8 |
📊 EMAMILTD presents strong profitability metrics with ROE at 31.5% and ROCE at 34.0%, indicating efficient capital utilization. The P/E ratio of 20.2 is significantly lower than the industry average (41.8), suggesting undervaluation. Dividend yield of 2.46% adds attractive shareholder returns. Debt-to-equity is negligible (0.01), reflecting financial stability. However, the PEG ratio of 25.6 signals overvaluation relative to growth, and technical indicators (RSI 23.0, MACD -20.2) show oversold conditions and weak momentum. FII holdings have declined (-1.90%), though DII holdings increased (+1.72%).
💡 Ideal Entry Price Zone: Current price is 406 ₹, very close to its 52-week low (404 ₹). An ideal entry zone would be 400 ₹–420 ₹, offering value near support levels. Accumulation is advisable if fundamentals remain stable and growth visibility improves.
📈 Exit Strategy / Holding Period: For existing holders, a medium-to-long-term holding (3–5 years) is recommended given strong ROE, ROCE, and dividend yield. Exit strategy could be considered if price approaches 640 ₹–655 ₹ (recent highs) without earnings support. Otherwise, continue holding for compounding benefits and dividend income.
✅ Positive
- Strong ROE (31.5%) and ROCE (34.0%) highlight efficient capital use.
- P/E ratio (20.2) is well below industry average (41.8), suggesting undervaluation.
- Dividend yield of 2.46% provides attractive shareholder returns.
- Low debt-to-equity ratio (0.01) ensures financial stability.
- Quarterly PAT growth (339 Cr. vs 182 Cr.) shows strong momentum.
⚠️ Limitation
- PEG ratio of 25.6 indicates overvaluation relative to growth.
- Stock trades below DMA 50 (473 ₹) and DMA 200 (529 ₹), showing technical weakness.
- Low 52-week index performance (0.72%) compared to peers.
📉 Company Negative News
- FII holdings decreased (-1.90%), showing reduced foreign confidence.
- Technical indicators (RSI 23.0, MACD -20.2) suggest oversold and weak momentum.
📈 Company Positive News
- DII holdings increased (+1.72%), reflecting domestic institutional support.
- Quarterly profit variation (+21.3%) indicates strong earnings growth.
- EPS of 19.8 ₹ supports valuation strength.
🏭 Industry
- Industry P/E is 41.8, much higher than company’s 20.2, suggesting EMAMILTD is undervalued relative to peers.
- FMCG sector outlook remains positive with steady demand and brand strength.
🔎 Conclusion
EMAMILTD is a fundamentally strong FMCG company with attractive valuation, high ROE/ROCE, and a healthy dividend yield. Current price near 406 ₹ offers a good entry opportunity for long-term investors, ideally between 400 ₹–420 ₹. Holding for 3–5 years is advisable, with exit considerations near 640 ₹–655 ₹ if valuations stretch without earnings support. Overall, the stock is a moderately strong candidate for long-term investment, though growth visibility needs to improve to justify higher valuations.